Endogenous and exogenous cardiac glycosides and their mechanisms of action. - Wikidata - wikimedia - TriplyDB

Endogenous and exogenous cardiac glycosides and their mechanisms of action.

Endogenous and exogenous cardiac glycosides and their mechanisms of action.

http://www.wikidata.org/entity/Q36870029

about

The Trade-Off between Dietary Salt and Cardiovascular Disease; A Role for Na/K-ATPase Signaling?Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease Calcium oscillations triggered by cardiotonic steroids Crystal structure of the high-affinity Na+,K+-ATPase-ouabain complex with Mg2+ bound in the cation binding site Regulation of neuronal bioenergy homeostasis by glutamate 21-Benzylidene digoxin: a proapoptotic cardenolide of cancer cells that up-regulates Na,K-ATPase and epithelial tight junctions Sodium-hydrogen exchange inhibition attenuates glycoside-induced hypertrophy in rat ventricular myocytes Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection Ouabain stimulates a Na+/K+-ATPase-mediated SFK-activated signalling pathway that regulates tight junction function in the mouse blastocyst.Normal pregnancy: mechanisms underlying the paradox of a ouabain-resistant state with elevated endogenous ouabain, suppressed arterial sodium calcium exchange, and low blood pressure The ouabain-binding site of the α2 isoform of Na,K-ATPase plays a role in blood pressure regulation during pregnancy Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo.Spherical Oligo-Silicic Acid SOSA Disclosed as Possible Endogenous Digitalis-Like Factor.Mania-like behavior induced by genetic dysfunction of the neuron-specific Na+,K+-ATPase α3 sodium pump.Effects of cardiotonic steroids on trabecular meshwork cells: search for mediator of ouabain-enhanced outflow facility.The cardiotonic steroid digitoxin regulates alternative splicing through depletion of the splicing factors SRSF3 and TRA2B Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury Ouabain-Sensitive alpha1 Na,K-ATPase enhances natriuretic response to saline load.Role of digoxin-like immunoreactive substance in the pathogenesis of transient tachypnea of newborn.Distribution of the Na,K-ATPase alpha subunit in the rat spiral ganglion and organ of corti.The cardiac glycoside binding site on the Na,K-ATPase alpha2 isoform plays a role in the dynamic regulation of active transport in skeletal muscle Role of endogenous cardiotonic steroids in sodium homeostasis.Pregnane glycosides interfere with steroidogenic enzymes to down-regulate corticosteroid production in human adrenocortical H295R cells Effects of pregnane glycosides on food intake depend on stimulation of the melanocortin pathway and BDNF in an animal model.Marinobufagenin enhances cardiac contractility in mice with ouabain-sensitive alpha1 Na+-K+-ATPase.The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension.Ouabain-induced internalization and lysosomal degradation of the Na+/K+-ATPase.Medicinal plants: a public resource for metabolomics and hypothesis development.The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: implication of epithelial-to-mesenchymal transition.The sodium pump and cardiotonic steroids-induced signal transduction protein kinases and calcium-signaling microdomain in regulation of transporter trafficking.The physiological significance of the cardiotonic steroid/ouabain-binding site of the Na,K-ATPase Na/K-ATPase Signaling and Salt Sensitivity: The Role of Oxidative Stress.Digoxin-induced retinal degeneration depends on rhodopsin.Mechanisms of ATP release, the enabling step in purinergic dynamics.Pharmacological management of hypertensive emergencies and urgencies: focus on newer agents.Natriuretic hormones in brain function.Personalized Therapy of Hypertension: the Past and the Future.Risk of cancer in patients with heart failure who use digoxin: a 10-year follow-up study and cell-based verification.HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies.ATP1A1-mediated Src signaling inhibits coronavirus entry into host cells.

P2860

Q26865026-E6162BBF-1807-4D24-9F70-69187F314D48 Q27011660-7B3E7747-7F5D-4923-909B-6926750B2B59 Q27024509-7AA60A7E-8F84-4592-8DD8-5C2F0B734853 Q27678678-2258BD73-A664-4AC3-8E92-A2214FB72277 Q28388014-6158A6BB-A958-40BC-89F9-5531CB56B4A5 Q28395505-D1E9D2EF-2118-409E-97A0-5D01EB9CB6A9 Q28568918-7C041CDB-A78B-42C6-A2EC-087DAB5C4501 Q28828878-BFEB4F3A-9BB0-4363-8FFA-61F1263B0A9B Q34013727-2774793B-B391-4AC3-92C7-3B9000F3C452 Q34247076-0C863EBA-0883-45FE-B7A1-C2C8C2183475 Q34530435-526E3973-DB2F-4DC4-B915-9ED98D912524 Q34786609-B26C10F5-60C9-4CE3-B5AC-8EDA6BDC0185 Q35005672-D64BC3A5-5FFC-49B6-8E7E-FF19C06269C4 Q35518878-7229652F-7B03-4D1F-9A7C-836FAF0BEB80 Q35812821-B8789A96-773E-4E09-A6A4-0585A08A5D6E Q35907914-657807F0-4922-4393-B65B-810414164137 Q36041722-42476B39-6882-4A7C-9C7A-F157C2269305 Q36906066-3F34498C-EAF9-492A-891F-6877EF182FFD Q37044089-F3B75849-5253-4579-93E4-E5FEC3F13BAD Q37101533-840442D9-B2A2-4C6A-85B5-CF12BB057279 Q37115158-61ED60FD-880E-44AE-8B3E-B009CA394E35 Q37192115-219746B7-58F6-4F92-ACCC-5E6BAE5FE58B Q37229289-1CEC14B7-B3ED-43A8-AEC4-2E6EBDB3363E Q37247912-0D2F120F-5AF2-4403-BE2B-F4E27C77C3A7 Q37276192-AB367E51-19AB-40EB-A1D9-36FB657F391C Q37307933-1EA1C79E-B174-4402-AA6A-ED71D8471BDE Q37459201-EAE6D142-59B7-4348-9999-CDB5C545854B Q37512653-4FD4B850-3E90-4DAB-B842-8FC8B6A644B8 Q37680502-8ACC5DE4-8C69-437B-B873-8E4E0E29224F Q37689977-14BA1B52-4A9D-4D5F-9687-A7CFB46C3B31 Q37690721-1549A621-38F6-429A-BBA7-E56EF2EB0754 Q37741230-60D31D8B-DB4D-405B-9EAF-1707D6637954 Q37745617-70956C22-736E-4C8A-AB58-357212ECF527 Q37969555-BBBE10D7-9B00-4044-A3D3-D8C16FC3E2FA Q38016205-5E2C52AE-4E94-4896-8D50-A2393A1DE241 Q38288274-B71293C4-A3E4-4E33-8B74-73469F333ACF Q38749985-C7BEB574-631E-4AAE-9E24-5C76DE3C7403 Q38790879-A1E8AD54-B653-4E80-89D2-924AFE855050 Q38825960-4ACCC183-5FB5-4619-9EF8-9F649F2E0680 Q38912734-864FA0ED-0DBF-433B-8719-665172A58D92

P2860

Endogenous and exogenous cardiac glycosides and their mechanisms of action.

http://www.wikidata.org/entity/Q36870029

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Endogenous and exogenous cardiac glycosides and their mechanisms of action.

@en

type

label

Endogenous and exogenous cardiac glycosides and their mechanisms of action.

@en

prefLabel

Endogenous and exogenous cardiac glycosides and their mechanisms of action.

@en

P1433

Q36870029-98619C6A-02FB-422C-A5AB-154C4CF0597E

P1476

Q36870029-D1AD5B7F-C89B-4B85-B56C-F475317FBE94

P2093

Q36870029-17F4A77B-11E1-44A4-BB70-FBADC624C9A0

Q36870029-5C0ED051-973F-4170-909D-226F199C9A74

P2860

Q36870029-0EB9D423-8022-4D9A-BB70-D13CAADA62CF

Q36870029-13EAB16D-2B71-4425-B6C3-7BE69F46A443

Q36870029-17C8A560-C81B-4A5C-9CAD-2D91B95453F2

Q36870029-1DE1D94B-16F5-4608-8787-C62A7DA51708

Q36870029-353DE83E-2D34-46E9-80AD-CB3C5878D8F4

Q36870029-3E02FD3C-7A95-46F7-A024-1193148A4905

Q36870029-472FC799-D928-48EA-A2CD-4B66F23B4BF7

Q36870029-48BC53D7-EDF8-431C-B2F1-4FDACDA71E91

Q36870029-4B5EE2E4-D67E-4543-82B7-63573A2D03DD

Q36870029-4B9AF765-C9EA-4508-9EB0-B7B6518BFCCB

P2888

Q36870029-12A72054-4559-422F-BB98-5D2AF818FB05

P304

Q36870029-E4EBFFFB-2407-486E-943C-4A0DF8607F74

P31

Q36870029-1366F9BA-3868-4FF6-8CF3-76FCFA7A001A

P356

Q36870029-5CBE7BDF-16CE-471D-9491-76D24E47F558

P433

Q36870029-89908B62-1EF0-4ED6-83C0-D2EDEDC6A71C

P478

Q36870029-0BB58FAD-42FB-4E2A-9092-2064AB0D4756

P577

Q36870029-8DDF651A-1CA4-4E25-B153-23898D11E153

P5875

Q36870029-96230121-F72F-4B35-BD64-C802DF019C40

P6179

Q36870029-BDFF6684-AAE3-4658-8C0A-4AD0C54A48DB

P698

Q36870029-49D3A0BE-4B1E-417B-8238-268856A2ADA1

P356

00129784-200707030-00004

P1433

American journal of cardiovascular drugs

P1476

Endogenous and exogenous cardiac glycosides and their mechanisms of action.

@en

P2093

Georgios Scheiner-Bobis

http://www.w3.org/2001/XMLSchema#string

Wilhelm Schoner

http://www.w3.org/2001/XMLSchema#string

P2860

Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.

Structure-activity relationships for the hypertensinogenic activity of ouabain: role of the sugar and lactone ring.

Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension.

How does salt retention raise blood pressure?

Physiological role of the alpha1- and alpha2-isoforms of the Na+-K+-ATPase and biological significance of their cardiac glycoside binding site.

Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension.

Digoxin. A neurohormonal modulator in heart failure?

Na+ pump alpha 2-subunit expression modulates Ca2+ signaling.

An increase in a circulating inhibitor of Na+,K+-dependent ATPase: a possible link between salt intake and the development of essential hypertension.

Stress-induced elevation of ouabainlike compound in rat plasma and adrenal.

P2888

00129784-200707030-00004

P304

173-189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/00129784-200707030-00004

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6228106

http://www.w3.org/2001/XMLSchema#string

P6179

1037437744

http://www.w3.org/2001/XMLSchema#string

P698

17610345

http://www.w3.org/2001/XMLSchema#string